SUBSCRIBE
Drivetime Radio

Drivetime Specialty is a free educational audio program covering a range of topics relevant to various medical specialists & physicians. Listen to our experienced medical broadcasters, moderating engaging discussions with leading experts.

Current programs include:

  • NEW Epilepsy – hosted by Prof Mark Cook, Neurologist, Melbourne
  • NEW Endocrinology – hosted by Prof Rod Baber, Obstetrician & Gynaecologist, Sydney
  • Neurology – hosted by Prof Mark Cook, Neurologist, Melbourne
  • Ophthalmology – hosted by Prof Paul Mitchell, Ophthalmologist, Sydney
  • Psychiatry – hosted by Prof Malcolm Hopwood, Psychiatrist, Melbourne
  • Respiratory – hosted by Prof John Upham, Respiratory Physician, Brisbane

More disciplines coming soon……

Podcasts are available for each series – providing a time efficient form of communication that’s convenient and easy to consume. Click here for podcast download instructions

You can also listen online – either search by your area of interest to filter interviews relevant to you, or if you are logged in you can click on specific programs below.

Interviews are provided exclusively for Australian healthcare professionals. Subscribe for free today to access all programs.

Search Interviews

By area of interest:

Specialty Interviews

Psy.5.1Considering long-term goals while managing the acute phase of schizophrenia (21 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry: Conventionally during the acute phase of psychosis, we’ve tended to focus on short-term treatment of intense positive symptoms, hostility and agitation, and may not consider long-term treatment goals such as the improvement of negative symptoms and cognitive deficits the way we might like. In this interview, we’re talking about the importance of considering long-term treatment goals of schizophrenia when treating patients with psychosis in the acute phase.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • A/Prof. Matthew Warden, Psychiatrist, St Vincent’s Hospital, Melbourne, AustraliaA/Prof. Matthew Warden, Psychiatrist, St Vincent’s Hospital, Melbourne, Australia
Psy.5.2Strategies for ‘the conversation’ around long-acting injectable antipsychotics in patients with schizophrenia (20 mins)
00:00
Preview
10 seconds
Show more information

NEW Psychiatry. Schizophrenia is a treatable condition, we have good treatments and treatment does lead to remission if we deliver the appropriate treatment. In this interview we discuss the biggest challenges that we face as a clinicians, particularly in patients with an established diagnosis of schizophrenia, as well as patient priorities and how we can balance trust in the relationship while making sure that they have the best outcome.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • A/Prof. Mark Taylor, Psychiatrist, Toowong Specialist Clinic, BrisbaneA/Prof. Mark Taylor, Psychiatrist, Toowong Specialist Clinic, Brisbane
Psy.5.3Choice of discharge antipsychotic – A community psychiatrist’s view (21 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry. Schizophrenia is a cyclical disease with approximately 94% of patients experiencing multiple episodes of psychosis. During periods of acute psychosis, patients may require hospitalisation, however eventually they will be discharged, and it’s during this period that transition care arrangements are very important. In this interview we discuss managing patients as they move from inpatient hospitalisation, back to community care.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Dr Rebecca Roma, Community Psychiatrist, Pittsburgh, USADr Rebecca Roma, Community Psychiatrist, Pittsburgh, USA
Epi.3Mechanism of action considerations when treating epilepsy (33 mins)
00:00
Preview
10 seconds
Show more information

Epilepsy: Drug development over 25 years has resulted in a variety of anti-epileptic drugs available to us in clinical neurology, and these utilise several different mechanisms of action (MoA). In this interview we discuss what should be considered as a part of that decision-making process when prescribing, including; MoA, the epilepsy syndrome, patient factors, and practical considerations.
33-minute listen

Hosted by

Professor Mark Cook

Interviewees

  • Dr Kaitlyn Parratt, Staff Specialist, Royal Prince Alfred Hospital, SydneyDr Kaitlyn Parratt, Staff Specialist, Royal Prince Alfred Hospital, Sydney
Epi.4A challenging time, moving from paediatric to adult care (30 mins)
00:00
Preview
10 seconds
Show more information

Epilepsy: In this interview we talk about the transition of moving from paediatric to adult care, which can be a challenging time for chronic health conditions and their caring network. Epilepsy is no exception, and poor adult psycho-social outcomes have been observed for those with paediatric onset epilepsy. Through intentional and thoughtful transition care programmes we can attempt to improve outcomes, listen to learn more.
30-minute listen

Hosted by

Professor Mark Cook

Interviewees

  • A/Prof. Piero Perucca, Neurologist, The Royal Melbourne HospitalA/Prof. Piero Perucca, Neurologist, The Royal Melbourne Hospital
  • Ms Evelyn Culnane, Transition Care ManagerMs Evelyn Culnane, Transition Care Manager
  • Dr Simon Harvey, Paediatric Epileptologist, The Royal Children’s HospitalDr Simon Harvey, Paediatric Epileptologist, The Royal Children’s Hospital
Res.5.1Evaluating different treatment strategies for mild asthma (22 mins)
00:00
Preview
10 seconds
Show more information

Respiratory. Asthma, superficially it seems simple to manage and mild asthma would seem simple to identify, but the more you look, the more you find there are differences and variations in the clinical expression and physiology. In this interview we discuss how to tailor treatment to each individual patient.

Hosted by

Professor John Upham

Interviewees

  • Prof. Greg King, Respiratory Physician, Royal North Shore Hospital, SydneyProf. Greg King, Respiratory Physician, Royal North Shore Hospital, Sydney
Res.5.2COPD treatment and the findings from the IMPACT study (13 mins)
00:00
Preview
10 seconds
Show more information

Respiratory. In this interview we discuss a recent study, the IMPACT study, which has looked at exacerbations and all-cause mortality differences in a head to head study comparing a number of inhaler strategies. This is an important study which answers some really important clinical questions.

Hosted by

Professor John Upham

Interviewees

  • Professor Greg King, Respiratory Physician, Royal North Shore Hospital, SydneyProfessor Greg King, Respiratory Physician, Royal North Shore Hospital, Sydney
Psy.4.1Key findings from the Metabolic Management during Antipsychotic Prescribing (MMAP) program (23 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry. People with schizophrenia are well known to be at risk of metabolic syndrome, and some of the medications we use increase that risk quite markedly. Recently an audit was conducted to identify patients with schizophrenia across Australia who have metabolic problems, and look at the various interventions that might be effective for them. In this interview we discuss the key findings.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Prof. David Castle, St Vincent’s Hospital Melbourne and the University of MelbourneProf. David Castle, St Vincent’s Hospital Melbourne and the University of Melbourne
Psy.4.2The importance of improving interest, pleasure and emotional range when treating major depressive disorder (15 mins)
00:00
Preview
10 seconds
Show more information

Psychiatry. When treating depression what do patients want, ‘to ameliorate depressive symptoms’ or ‘to return to normal functioning’? In this interview we discuss individualised management that takes patient’s symptoms priorities and treatment expectations into account.

Hosted by

Professor Malcolm Hopwood

Interviewees

  • Prof. David Castle, St Vincent’s Hospital Melbourne and the University of MelbourneProf. David Castle, St Vincent’s Hospital Melbourne and the University of Melbourne
Epi.1We now have more options in the medical treatment of epilepsy: A case study review (30 mins)
00:00
Preview
10 seconds
Show more information

Epilepsy: Epilepsy is one of the most common neurological illnesses, affecting three to four per cent of people in the developing world, and while we have a wealth of treatment options, many of these are now very old. In this interview we focus on the treatment options available to us as physicians and look at what this means to the patient and what factors we ought to consider.
30-minute listen

Hosted by

Professor Mark Cook

Interviewees

  • Associate Professor Piero Perucca, Neurologist, Royal Melbourne Hospital, Alfred Hospital, MelbourneAssociate Professor Piero Perucca, Neurologist, Royal Melbourne Hospital, Alfred Hospital, Melbourne

Search Interviews

By area of interest:

Exclusively for Australian healthcare professionals
×

Tap the share icon ios share icon and select 'Add to Home Screen' to add the site to your home screen for quick access!